The regulatory file for alpha-lipoic acid
Racemic alpha-lipoic acid is supplied as CAS 1077-28-7, C8H14O2S2, molecular weight 206.33. The catalog specification is the starting point; the regulatory file is built around the exact optical form, the destination and the finished-product route, and the buyer's regulatory team confirms that route. This page lists the documents and checks that belong in the file so that the specification, the label and the commercial pack can be reviewed together.
The specification describes the powder; the regulatory file has to show that the named form is allowed, that the dose and contaminants add up, and that the label says the same thing.
What the file contains
A complete file answers four practical questions. What is the material, and which version of the specification is being bought? Which lot is being released, and what does its certificate report? Which limits and label rules apply to the finished product in the destination? What changes if the source, the process or the pack changes? The certificate answers the lot question, the technical data sheet answers the specification question and the safety data sheet answers the handling question; none of them answers the route question alone.
The file should also contain an allergen statement, a GMO statement, an origin record, a residual-solvent statement and a statement of the optical form. The material itself is a small molecule, but the carrier and any processing aid can change the allergen answer, so the statement should cover the lot and the pack.
European Union
The EU file is built from the specification, the contaminant results and the label. General food law, labelling and contaminant rules apply alongside any product-specific route; whether a novel-food authorisation, a notification or a history-of-use position applies is a question for the buyer's regulatory team, and the current consolidated text is the reference. As of this review, we do not assert that the material is authorised as a novel food for any market; the buyer confirms the route for the destination.
The optical form matters here. A file written around racemic alpha-lipoic acid does not automatically cover R-alpha-lipoic acid, which has a different CAS number and may be named differently in a product-specific entry. If the label says R-ALA, the regulatory citation has to match the R-form, not the racemic grade.
United States
The US file is built around the exact dietary ingredient and its intended use. The supplier should be able to name the basis it relies on and point to the supporting document; the buyer confirms that the basis covers the finished product, the dose and the claim. The Supplement Facts panel names the ingredient, and the optical form should be written out rather than abbreviated. The label and the claim are reviewed separately from the certificate.
Where the finished product is a food rather than a supplement, the route is different again, and the intended use has to be stated on the enquiry so the documents match it.
United Kingdom
Great Britain and Northern Ireland are checked separately. The GB file uses the current GB register and GB labelling rules; Northern Ireland follows the EU framework. The buyer's regulatory team confirms which of the two applies and keeps the evidence with the order. Do not carry an EU conclusion across to Great Britain without checking it.
Contaminants and limits
The contaminant panel is a finished-product calculation, not only a drum result. The table is the starting point for a supplement file; the destination text and the daily dose decide the final limit.
| Parameter | Catalog limit | What the file should show |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Lot result, method, limit and the finished-product calculation |
| Arsenic (As) | ≤2 mg/kg | Lot result, method and the agreed limit |
| Cadmium (Cd) | ≤1 mg/kg | Lot result and any category exception that applies |
| Mercury (Hg) | ≤0.1 mg/kg | Lot result and method |
The calculation matters because the ingredient is a small fraction of the capsule. A lot that meets the drum limit can still be too high when the daily dose is large, and a lot that is close to the limit leaves no room for a second source in the same formula.
Label and claims
No disease-related claim is made for this material, and none should be inferred from the specification. The claim review belongs to the brand and its regulatory reviewer, who confirm that the wording is allowed for the product, the form and the market. Structure or function wording, the word “antioxidant” and any reference to the R-form are all claim questions, not specification questions.
The label must name the form that the file covers. A racemic powder cannot support an R-ALA claim, and an R-form lot cannot be described as plain alpha-lipoic acid if the destination requires the optical form to be declared. A claim does not change the specification, and the certificate does not approve a claim.
The documents and their versions
The file should be a list with versions and dates, not a folder of undated PDFs:
- Specification, with the optical form, CAS number and version number.
- Certificate of analysis for the lot, with the methods and the results.
- Technical data sheet and safety data sheet.
- Allergen, GMO, origin and residual-solvent statements.
- Statement of the optical form and, for the R-form, the enantiomeric purity result.
- Stability summary for the pack being bought.
- Packaging declaration, including the liner and the net weight.
Checklist before the first order
- The optical form, CAS number and specification version are named on the order.
- The COA, TDS, SDS, allergen, GMO, origin and residual-solvent statements are on file.
- The contaminant results are converted to the finished-product dose.
- The label names the same form as the regulatory file.
- The claim wording has been reviewed for the destination.
- The source, process and pack are under change control.
- The quotation, the specification and the certificate refer to the same version.
The product hub carries the catalog specification; the COA page explains the lot certificate; the identity page covers the analytical evidence; the quality page describes the release file; the EU regulatory notes give the framework references. The glutathione range is a useful comparison for another sulfur-containing ingredient with its own form question.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation